Mesosulfuron-methyl

DB15184ExperimentalSmall molecule

Mesosulfuron-methyl is under investigation in clinical trial NCT01118117 (A Multi-center Clinical Trial of the Misago™ Self-Expanding Stent System for Superficial Femoral Artery).

Mechanism: Pharmacologically active on Acetolactate synthase, catabolic
Curator reviewed
Formula / weight: C₁₇H₂₁N₅O₉S₂ · 503.507 g/mol (avg)
Also known as: 2-(((((4,6-DIMETHOXY-2-PYRIMIDINYL)AMINO)CARBONYL)AMINO)SULFONYL)-4-(((METHYLSULFONYL)AMINO)METHYL)BENZOIC ACID METHYL ESTER · METHYL 2-(3-(4,6-DIMETHOXYPYRIMIDIN-2-YL)UREIDOSULFONYL)-4-METHANESULFONAMIDOMETHYLBENZOATE · OSPREY · SILVERADO
Code names: AE-F130060

Resolves to

Compound

UNII22L00R79A6CAS208465-21-8ChEMBLCHEMBL1883630

Structure

InChIKeyNIFKBBMCXCMCAO-UHFFFAOYSA-NSMILESCOC(=O)C1=C(C=C(CNS(C)(=O)=O)C=C1)S(=O)(=O)NC(=O)NC1=NC(OC)=CC(OC)=N1

Targets

P27696budB

What you can answer from here — as of September 20, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

4+ReferencesStructured and connected to the statements they support

Which drugs share a target with Mesosulfuron-methyl, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account